Related references
Note: Only part of the references are listed.Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials
Lorna K. Henderson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia
Michael D. Tarantino et al.
BLOOD COAGULATION & FIBRINOLYSIS (2013)
Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
James B. Bussel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: A meta-analysis
Li Feng et al.
NEPHROLOGY (2013)
Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
Marc Weidenbusch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Candido Diaz-Lagares et al.
AUTOIMMUNITY REVIEWS (2012)
Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus
Md Nazrul Islam et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
Daniel J. Wallace et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome
Desmond Y. H. Yap et al.
NEPHROLOGY (2012)
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
Xiao Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
Wei Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: A multicenter, randomized, double-blind, vehicle-controlled trial
Annegret Kuhn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Acute lupus myocarditis: Clinical features and outcome
S. Appenzeller et al.
LUPUS (2011)
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
G. Ruiz-Irastorza et al.
LUPUS (2011)
Rituximab Therapy in Refractory Neuropsychiatric Lupus: Current Clinical Evidence
Javier Narvaez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
G. K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis
Ellen M. Ginzler et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus
A. Raptopoulou et al.
LUPUS (2010)
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study
J. Zavada et al.
LUPUS (2010)
The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review
E. Rosenbaum et al.
LUPUS (2009)
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension
Xavier Jais et al.
ARTHRITIS AND RHEUMATISM (2008)
Massive intractable pericardial effusion in a patient with systemic lupus erythematosus treated successfully with pericardial fenestration alone
Y. Kamata et al.
LUPUS (2008)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Clinical characteristics of lupus myocarditis in Korea
Jae-Wook Chung et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura
L. M. Aledort et al.
HEMATOLOGY (2007)
Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus
Masayoshi Sugano et al.
JOURNAL OF DERMATOLOGY (2006)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension
Olivier Sanchez et al.
CHEST (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature
AM Milstone et al.
CLINICAL RHEUMATOLOGY (2005)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
P Brændstrup et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
L Barile-Fabris et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Large pericardial effusions due to systemic lupus erythematosus: a report of eight cases
HSH Weich et al.
LUPUS (2005)
Acute lupus myrocarditis: clinical features and outcome of an oriental case series
WG Law et al.
LUPUS (2005)
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative
CE Lampropoulos et al.
RHEUMATOLOGY (2004)
Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis
YK Chan et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2003)
Vascular events in hypertensive patients with systemic lupus erythematosus
P Rahman et al.
LUPUS (2000)
Share Paper
